Mangoceuticals, Inc.
MGRX- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- SEC CIK
- 0001938046
No open-market purchases or sales by Mangoceuticals, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $455.6K in total; no superinvestor holds it.
Holders of 5% or more of MGRX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Mangoceuticals, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Cohen Jacob D. | 13D/A | 14.60%2.04M shares | +3.60 ppfrom 11.00% | Apr 11, 20252 filings | Sep 30, 2025 | SEC |
| Greenfield Investments Ltd. | 13G | 14.44%515.0K shares | New | Jan 22, 20251 filing | Jan 22, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
3 Schedule 13D and 13G filings on Mangoceuticals, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Sep 30, 20254:59 PM ET | Cohen Jacob D.and 1 other | 13D/A | 14.60%2.04M shares | +3.60 ppfrom 11.00% | Jul 21, 2025 | SEC |
| Apr 11, 20255:00 PM ET | Cohen Jacob D.and 1 other | 13D/A | 11.00%921.7K shares | – | Apr 10, 2025 | SEC |
| Jan 22, 20255:28 PM ET | Greenfield Investments Ltd.and 1 other | 13G | 14.44%515.0K shares | New | Dec 13, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Mangoceuticals, Inc. shares.
No Form 144 notices for Mangoceuticals, Inc. are on file.